Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription 17.08.2020 1 Am J Respir Crit Care Med 1 Ann Surg 1 Ann Thorac Surg 1 BMC Cancer 2 Cancer Cell 1 Cancer Chemother Pharmacol 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 5 Cancer Sci 1 Clin Lung Cancer 1 Eur J Cardiothorac Surg 2 J Clin Oncol 1 J Immunol 2 J Surg Oncol 2 J Thorac Cardiovasc Surg 1 J Thorac Oncol 3 Lancet 1 Lancet Oncol 1 Lancet Respir Med 3 Lung Cancer 1 Lung Cancer (Auckl) 1 N Engl J Med 5 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. NISHIZAWA S, Tobino K
   Asymptomatic Tuberculous Pleurisy Mimicking Mesothelioma.
   Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201906-1223.
   PubMed        
   
   

   
   Ann Surg

2. BEST TD, Mercaldo SF, Bryan DS, Marquardt JP, et al
   Multilevel Body Composition Analysis on Chest Computed Tomography Predicts Hospital Length of Stay and Complications After Lobectomy for Lung Cancer: A Multicenter Study.
   Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004040.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. TURNER SR, Lai H, Nasir BS, Yasufuku K, et al
   Development and Pilot Testing of an Assessment Tool for Performance of Anatomic Lung Resection.
   Ann Thorac Surg. 2020;109:1922-1930.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. RAMELOW J, Brooks CD, Gao L, Almiman AA, et al
   The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models.
   BMC Cancer. 2020;20:738.
   PubMed         Abstract available
   
   

   
   Cancer Cell

5. HEGDE S, Krisnawan VE, Herzog BH, Zuo C, et al
   Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
   Cancer Cell. 2020;37:289-307.
   PubMed         Abstract available
   
   
6. LIU H, Kuang X, Zhang Y, Ye Y, et al
   ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
   Cancer Cell. 2020;37:324-339.
   PubMed         Abstract available
   
   

   
   Cancer Chemother Pharmacol

7. AHMAD Z, Jacobson BA, McDonald MW, Vattendahl Vidal N, et al
   Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma.
   Cancer Chemother Pharmacol. 2020;85:425-432.
   PubMed         Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

8. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
   Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
   Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
   PubMed         Abstract available
   
   

   
   Cancer Lett

9. VANBERVLIET-DEFRANCE B, Delaunay T, Daunizeau T, Kepenekian V, et al
   Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
   Cancer Lett. 2020;472:29-39.
   PubMed         Abstract available
   
   

   
   Cancer Sci

10. ICHIKI Y, Shigematsu Y, Baba T, Shiota H, et al
    Development of adoptive immunotherapy with KK-LC-1 specific TCR transduced gammadelta T cells against lung cancer cells.
    Cancer Sci. 2020 Aug 11. doi: 10.1111/cas.14612.
    PubMed         Abstract available
    
    
11. KAWASAKI K, Nojima S, Hijiki S, Tahara S, et al
    FAM111B enhances proliferation of KRAS-driven lung adenocarcinoma by degrading p16.
    Cancer Sci. 2020;111:2635-2646.
    PubMed         Abstract available
    
    
12. KAGAWA Y, Furuta H, Uemura T, Watanabe N, et al
    Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer.
    Cancer Sci. 2020 Aug 7. doi: 10.1111/cas.14605.
    PubMed         Abstract available
    
    
13. SATA Y, Nakajima T, Fukuyo M, Matsusaka K, et al
    High expression of CXCL14 is a biomarker of lung adenocarcinoma with micropapillary pattern.
    Cancer Sci. 2020;111:2588-2597.
    PubMed         Abstract available
    
    
14. HU M, Zhao Y, Cao Y, Tang Q, et al
    DRP1 promotes lactate utilization in KRAS-mutant non-small cell lung cancer cells.
    Cancer Sci. 2020 Aug 7. doi: 10.1111/cas.14603.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

15. WONG W, Wu N, Gupta R, Mansfield AS, et al
    Utilization Trends and Factors Associated With ROS1 Testing Among Patients With Advanced Non-small-cell Lung Cancer in US Community Practices.
    Clin Lung Cancer. 2020 Jun 29. pii: S1525-7304(20)30213.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

16. CHIAPPETTA M, Lococo F, Leuzzi G, Sperduti I, et al
    External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
    Eur J Cardiothorac Surg. 2020 Aug 8. pii: 5885289. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

17. CAMIDGE DR, Kim HR, Ahn MJ, Yang JCH, et al
    Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
    J Clin Oncol. 2020 Aug 11:JCO2000505. doi: 10.1200/JCO.20.00505.
    PubMed         Abstract available
    
    
18. FARJAH F, Grau-Sepulveda MV, Gaissert H, Block M, et al
    Volume Pledge is Not Associated with Better Short-Term Outcomes After Lung Cancer Resection.
    J Clin Oncol. 2020 Aug 7:JCO2000329. doi: 10.1200/JCO.20.00329.
    PubMed         Abstract available
    
    

    
    J Immunol

19. WANG L, Zeng W, Wang L, Wang Z, et al
    Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation.
    J Immunol. 2019 Dec 23. pii: jimmunol.1900278. doi: 10.4049/jimmunol.1900278.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

20. KORYLLOS A, Lopez-Pastorini A, Zalepugas D, Galetin T, et al
    Optimal timing of surgery for bronchial sleeve resection after neoadjuvant chemoradiotherapy.
    J Surg Oncol. 2020;122:328-335.
    PubMed         Abstract available
    
    
21. MINAMI K, Jimbo N, Tanaka Y, Ogawa H, et al
    Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    J Surg Oncol. 2020;122:243-253.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

22. TAKAHASHI M, Sowa T, Tokumasu H, Gomyoda T, et al
    Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 29. pii: S0022-5223(20)31751.
    PubMed         Abstract available
    
    
23. STILES BM, Sepesi B, Broderick SR, Bott MJ, et al
    Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31987.
    PubMed        
    
    

    
    J Thorac Oncol

24. YANG Y, Wang Z, Fang J, Yu Q, et al
    Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11).
    J Thorac Oncol. 2020 Jul 31. pii: S1556-0864(20)30595.
    PubMed         Abstract available
    
    

    
    Lancet

25. SZTURZ P, Vermorken JB
    Further clinical interpretation and implications of KEYNOTE-048 findings.
    Lancet. 2020;396:379.
    PubMed        
    
    
26. REVANNASIDDAIAH S, Devadas SK, Maka VV, Kilara N, et al
    Further clinical interpretation and implications of KEYNOTE-048 findings.
    Lancet. 2020;396:378.
    PubMed        
    
    
27. MCCAW ZR, Ludmir EB, Kim DH, Wei LJ, et al
    Further clinical interpretation and implications of KEYNOTE-048 findings.
    Lancet. 2020;396:378-379.
    PubMed        
    
    

    
    Lancet Oncol

28. MARINGE C, Spicer J, Morris M, Purushotham A, et al
    The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Lancet Oncol. 2020 Jul 20. pii: S1470-2045(20)30388.
    PubMed         Abstract available
    
    

    
    Lancet Respir Med

29. HATABU H, Hunninghake GM, Richeldi L, Brown KK, et al
    Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.
    Lancet Respir Med. 2020;8:726-737.
    PubMed         Abstract available
    
    

    
    Lung Cancer

30. WANG Z, Zhao J, Ma Z, Cui J, et al
    A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients.
    Lung Cancer. 2020;147:259-268.
    PubMed         Abstract available
    
    
31. BARTLETT EC, Kemp SV, Ridge CA, Desai SR, et al
    Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
    Lung Cancer. 2020;148:12-19.
    PubMed         Abstract available
    
    
32. SURYAVANSHI M, Jaipuria J, Panigrahi MK, Goyal N, et al
    CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer.
    Lung Cancer. 2020;148:33-39.
    PubMed         Abstract available
    
    

    
    Lung Cancer (Auckl)

33. NOGUCHI S, Suminaga K, Kaki T, Kawachi H, et al
    Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer.
    Lung Cancer (Auckl). 2020;11:53-57.
    PubMed         Abstract available
    
    

    
    N Engl J Med

34. HOWLADER N, Forjaz G, Mooradian MJ, Meza R, et al
    The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
    N Engl J Med. 2020;383:640-649.
    PubMed         Abstract available
    
    

    
    PLoS One

35. LEVEQUE E, Lacourt A, Philipps V, Luce D, et al
    A new trajectory approach for investigating the association between an environmental or occupational exposure over lifetime and the risk of chronic disease: Application to smoking, asbestos, and lung cancer.
    PLoS One. 2020;15:e0236736.
    PubMed         Abstract available
    
    
36. MEIKLE CK, Meisler AJ, Bird CM, Jeffries JA, et al
    Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis.
    PLoS One. 2020;15:e0236966.
    PubMed         Abstract available
    
    
37. GRATZ M, Ruhlmann V, Umutlu L, Fenchel M, et al
    Impact of respiratory motion correction on lesion visibility and quantification in thoracic PET/MR imaging.
    PLoS One. 2020;15:e0233209.
    PubMed         Abstract available
    
    
38. NASRI NASRABADI P, Nayeri Z, Gharib E, Salmanipour R, et al
    Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers.
    PLoS One. 2020;15:e0233717.
    PubMed         Abstract available
    
    
39. KLINGLER A, Regensburger D, Tenkerian C, Britzen-Laurent N, et al
    Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.
    PLoS One. 2020;15:e0233422.
    PubMed         Abstract available
    
    

    
    Thorax

40. HORST C, Dickson JL, Tisi S, Ruparel M, et al
    Delivering low-dose CT screening for lung cancer: a pragmatic approach.
    Thorax. 2020 Aug 13. pii: thoraxjnl-2020-215131.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: